CDSCO Revises Public Hearing Schedule
New Delhi: Through a recent notice, the Central Drugs Standard Control Organisation (CDSCO), the Directorate General of Health Services,the Ministry of Health and Family Welfare, has revised the public hearing schedule at their Public Relations Office (PRO) in the interest of strengthening regulatory guidance for stakeholders and innovators.
This revision builds upon earlier notices dated 04.10.2019, 10.12.2021, and 22.02.2022, aiming to improve access and streamline regulatory consultations.
The notice mentioned, "The schedule is revised in the public interest."
As per the revised schedule, the PRO at CDSCO (HQ), New Delhi, will be operational every day except holidays from 4:00 PM to 6:00 PM in the following manner to strengthen the process of regulatory guidance to stakeholders and innovators. However, it is further noted that on Monday, stakeholders may visit from 3:00 PM till 6:00 PM.
Day | Name of Division |
Monday | Medical Device & IVD (3:00 PM – 6:00 PM) |
Tuesday | New Drug, IND, SND & International Cell |
Wednesday | Import & Registration, FDC & LVP |
Thursday | Biologicals, Blood Products/Blood Centre & Ayush |
Friday | BA/BE, Ethics Committee, GCT, CRO Registration, CDAC/IT Cell, Veterinary & Cosmetics |
In addition to the above, the notice stated that all stakeholders may avail themselves of the facilities as per their requirements.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.